Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026)

Bicycle Therapeutics has reported Other Operating Expenses for 5 years, with the latest figure at -$2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 15.69% year-over-year to -$2.5 million; the trailing twelve-month figure through Mar 2026 stood at -$9.9 million (down 7.56% YoY), and the FY2025 full-year result was -$9.6 million, down 5.86% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$2.5 million, up from -$2.6 million in the prior quarter.
• The five-year high for Other Operating Expenses was -$1.9 million in Q2 2024, with the low at -$2.6 million in Q4 2024.
• Historically, Other Operating Expenses has averaged -$2.4 million across 3 years, with a median of -$2.5 million in 2025.
• The largest YoY upside for Other Operating Expenses was 2.29% in 2025 against a maximum downside of 21.45% in 2025.
• Bicycle Therapeutics' Other Operating Expenses stood at -$2.6 million in 2024, then changed by 0.0% to -$2.6 million in 2025, then advanced by 1.82% to -$2.5 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.5 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.